Biocon Limited announced changes to its board and statutory auditors at its 48th Annual General Meeting (AGM) held on August 6, 2026. Mr. Eric Vivek Mazumdar was re-appointed as a director, while Mr. Nicholas Robert Haggar completed his term as an independent director. The company also appointed S.R. Batliboi & Associates LLP as its new statutory auditors for a term of five years, succeeding B S R & Co. LLP.
Biocon Board and Auditor Appointments Confirmed at 48th AGM
Biocon Limited has announced key changes in its directorial and statutory auditor appointments following its 48th Annual General Meeting (AGM), which was held on Thursday, August 06, 2026. These changes are in line with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Director Re-appointment and Cessation
At the AGM, Mr. Eric Vivek Mazumdar (DIN: 09381549) was re-appointed as a Director, liable to retire by rotation. This re-appointment confirms his continued role on the board. Concurrently, Mr. Nicholas Robert Haggar (DIN: 08518863) ceased to be an Independent Director upon the completion of his term.
New Statutory Auditors Appointed
The company also confirmed the appointment of new statutory auditors. The term of the previous auditors, B S R & Co. LLP, expired at the conclusion of the 48th AGM. Following this, S.R. Batliboi & Associates LLP, Chartered Accountants, have been appointed as the new statutory auditors. They will hold this position for a term of five consecutive years, commencing from the conclusion of the 48th AGM until the conclusion of the 53rd AGM, expected in 2031. S.R. Batliboi & Associates LLP is registered with the ICAI under Firm Registration No. 101049W/E300004.
Confirmation on Director Eligibility
Biocon has also confirmed that Mr. Eric Vivek Mazumdar is not debarred from holding the office of Director by any order of the Securities and Exchange Board of India (SEBI) or any other relevant authority, as per the circular dated June 20, 2018, issued by the Stock Exchanges.
Source: BSE
